Agne Paner

118 posts

Agne Paner

Agne Paner

@PanerAgne

Director of Multiple Myeloma and Amyloidosis program at Rush University Medical Center

Chicago, IL Katılım Aralık 2018
93 Takip Edilen215 Takipçiler
Agne Paner retweetledi
.
.@IreneGhobrial·
Going for a run in the morning with my ⁦@PromiseStudy⁩ shirt. A woman stopped me because her mom and other family have myeloma. She wants to screen. ⁦@PromiseStudy⁩ #mmsm
. tweet media
English
1
5
87
0
Agne Paner retweetledi
Suzanne Lentzsch, MD, PhD
Suzanne Lentzsch, MD, PhD@SLentzsch·
Please see the CDC recommendation on tightly fitted 😷. Below are easy options to make sure that your mask fits tightly to your face ➡️try knotted ear loops and tucked-in sides of you surgical mask
CDC@CDCgov

In lab tests with dummies, exposure to potentially infectious aerosols decreased by about 95% when they both wore tightly fitted masks, a new @CDCMMWR finds. #WearAMask that fits tightly to your face to stop the spread of #COVID19. More: bit.ly/MMWR21021.

Paramus, NJ 🇺🇸 English
0
1
1
0
Agne Paner retweetledi
Mia Levy, MD, PhD
Mia Levy, MD, PhD@DrMiaLevy·
As access to the #COVIDVaccines widens, it's important to have all the facts in order to make an informed decision, particularly if you have a history of cancer. @RushCancer, we have provided this resource to help answer any lingering questions. rsh.md/3sXK4ks
English
1
6
11
0
Ajay Nooka, MD, MPH
Ajay Nooka, MD, MPH@AjayNookaMD·
⁦@WinshipAtEmory⁩ ⁦⁩ ⁦@kaufman_MMdoc⁩ spouse of one of my patients on my high-risk maintenance trial promised a painting every year that he is with us - soon I am making preparations for a flock and need a bigger desk
Ajay Nooka, MD, MPH tweet mediaAjay Nooka, MD, MPH tweet media
English
4
3
45
0
Luciano J Costa
Luciano J Costa@End_myeloma·
Found this practical tool to decide if one should get the #COVID vaccine
Luciano J Costa tweet media
English
4
13
85
0
Agne Paner retweetledi
Suzanne Lentzsch, MD, PhD
Suzanne Lentzsch, MD, PhD@SLentzsch·
Phase 3 TOURMALINE-MM2: IRd Vs Rd for non-ACST NDMM by Thierry Facon ➡️No significant difference in PFS and OS ➡️but⬆️PFS by 13.5 mos for IRD ➡️VGPR 63 vs 47.7% DRd is the winner but IRD still better than RD bacuse of meaningful clinical benefit #ASH20 #ASH20SL #mmsm
Suzanne Lentzsch, MD, PhD tweet mediaSuzanne Lentzsch, MD, PhD tweet mediaSuzanne Lentzsch, MD, PhD tweet mediaSuzanne Lentzsch, MD, PhD tweet media
English
2
5
10
0
Agne Paner retweetledi
Suzanne Lentzsch, MD, PhD
Suzanne Lentzsch, MD, PhD@SLentzsch·
My favorite topic #amyloidosis: Update on Andromeda Dara-CyBorD vs CyBorD by Ray Comenzo ➡️Dara-CyBorD results in longer PFS ➡️Dara-CyBorD significantly delays organ deterioration Dara-CyBorD is clearly the new SOC in AL! But is Dara maintenance also the new SOC? #ASH20 #ASH20SL
Suzanne Lentzsch, MD, PhD tweet mediaSuzanne Lentzsch, MD, PhD tweet mediaSuzanne Lentzsch, MD, PhD tweet mediaSuzanne Lentzsch, MD, PhD tweet media
English
2
31
89
0
Agne Paner retweetledi
C. Ola Landgren, M.D.
C. Ola Landgren, M.D.@DrOlaLandgren·
The Annual Myeloma MRD meeting has evolved from a “local” NYC meeting with 20-30 people back in 2014 -> today we had 400 participants worldwide! Excellent presentations & forward looking debates and discussions. Thank you all for working together & sharing your knowledge! #mmsm
Multiple Myeloma RF@theMMRF

Virtual #MyelomaMRD20 is underway! @DrOlaLandgren gives the introduction and overview.

English
2
8
36
0

Keşfet

@MCWCancerCenter @MCW_Research @bhemato @MeeraMohanMD @PromiseStudy @AmyloidosisSupp @MorieGertz @RushCancer